Loading…

The incidence, treatment strategies and outcomes of acute coronary syndromes in the “reperfusion network” of different hospital types in the Czech Republic: Results of the Czech evaluation of acute coronary syndromes in hospitalized patients (CZECH) registry

Abstract Aims To analyze the incidence, treatment strategies and outcomes of acute coronary syndromes (ACS) in Czech population. Methods and results ACS diagnosis was confirmed in 1345 of 1921 (70%) consecutively admitted patients with suspected ACS. ACS incidence was 3248 cases/million/year and the...

Full description

Saved in:
Bibliographic Details
Published in:International journal of cardiology 2007-07, Vol.119 (2), p.212-219
Main Authors: Widimsky, Petr, Zelizko, Michal, Jansky, Petr, Tousek, Frantisek, Holm, Frantisek, Aschermann, Michael
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c511t-1ca40e2fcc44bf738454d55d02c8a875fe76acfd4d9ddc8f39d21c9ee5e13cd3
cites cdi_FETCH-LOGICAL-c511t-1ca40e2fcc44bf738454d55d02c8a875fe76acfd4d9ddc8f39d21c9ee5e13cd3
container_end_page 219
container_issue 2
container_start_page 212
container_title International journal of cardiology
container_volume 119
creator Widimsky, Petr
Zelizko, Michal
Jansky, Petr
Tousek, Frantisek
Holm, Frantisek
Aschermann, Michael
description Abstract Aims To analyze the incidence, treatment strategies and outcomes of acute coronary syndromes (ACS) in Czech population. Methods and results ACS diagnosis was confirmed in 1345 of 1921 (70%) consecutively admitted patients with suspected ACS. ACS incidence was 3248 cases/million/year and the annual incidence of confirmed myocardial infarction was 1960 per million. In-hospital mortality was 5.1% (10.0% with Q-MI, 4.4% with non-Q-MI, and 0.9% with UAP). Coronary angiography was performed in 92% of STEMI (followed by primary PCI in 83%, by CABG in 3%, by conservative therapy in 6%). Thrombolysis was used in only 1% of patients. Reperfusion therapy was thus used in 87% of all STEMI patients. Discharge medication included aspirin in 95%, a statin in 76%, a beta-blocker in 78%, an ACE inhibitor in 50%, clopidogrel in 60%, and ticlopidine in 4% of patients. Conclusions In-hospital mortality of ACS in the Czech network of PCI and non-PCI hospitals is low. Nationwide application of primary PCI strategy for STEMI is feasible and increases the overall use of reperfusion therapy.
doi_str_mv 10.1016/j.ijcard.2007.02.036
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70573609</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S016752730700527X</els_id><sourcerecordid>70573609</sourcerecordid><originalsourceid>FETCH-LOGICAL-c511t-1ca40e2fcc44bf738454d55d02c8a875fe76acfd4d9ddc8f39d21c9ee5e13cd3</originalsourceid><addsrcrecordid>eNqFUs2O0zAQDoifLQtvgJAvIJBosRMnTjggoWphkVZCgh4QF8sdT6i7qR1sZ1H3tA8CL7dPgrMtqsRl5cPY8vfj8TdZ9pTRGaOserOemTUor2c5pWJG8xktqrvZhNWCT5ko-b1skmBiWuaiOMoehbCmlPKmqR9mR0xwnqc1ufNgsUJiLBiNFvA1iR5V3KCNJESvIv4wGIiymrghgtukg2uJgiEiAeedVX5LwtZqf3NnLIlJ7_rqt8cefTsE4yyxGH85f3599Wcka9O26EeHlQu9iaojcdsfyPNLhBX5gv2w7Ay8TbswdPHG93CNF6obVBzVb3nPPxNziZr0iZKcA3k5_34yP31FfGowNbp9nN1vVRfwyb4eZ4sPJ4v56fTs88dP8_dnUygZi1MGilPMWwDOl60oal5yXZaa5lCrWpQtikpBq7lutIa6LRqdM2gQS2QF6OI4e7GT7b37OWCIcmMCYNcpi24IUtBSFBVtEpDvgOBdCB5b2XuzSc1JRuUYv1zLXfxyjF_SXKb4E-3ZXn9YblAfSPu8E-D5HqACqK71KkUfDri6zqtKiIR7t8Nh-owLg14GMOOEaOMRotTO3PaS_wWgM9Ykz3PcYli7wdv00ZLJkAjy6ziq46RSQWmq34q_3VXuaw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70573609</pqid></control><display><type>article</type><title>The incidence, treatment strategies and outcomes of acute coronary syndromes in the “reperfusion network” of different hospital types in the Czech Republic: Results of the Czech evaluation of acute coronary syndromes in hospitalized patients (CZECH) registry</title><source>Elsevier</source><creator>Widimsky, Petr ; Zelizko, Michal ; Jansky, Petr ; Tousek, Frantisek ; Holm, Frantisek ; Aschermann, Michael</creator><creatorcontrib>Widimsky, Petr ; Zelizko, Michal ; Jansky, Petr ; Tousek, Frantisek ; Holm, Frantisek ; Aschermann, Michael ; on behalf of the CZECH investigators ; CZECH investigators</creatorcontrib><description>Abstract Aims To analyze the incidence, treatment strategies and outcomes of acute coronary syndromes (ACS) in Czech population. Methods and results ACS diagnosis was confirmed in 1345 of 1921 (70%) consecutively admitted patients with suspected ACS. ACS incidence was 3248 cases/million/year and the annual incidence of confirmed myocardial infarction was 1960 per million. In-hospital mortality was 5.1% (10.0% with Q-MI, 4.4% with non-Q-MI, and 0.9% with UAP). Coronary angiography was performed in 92% of STEMI (followed by primary PCI in 83%, by CABG in 3%, by conservative therapy in 6%). Thrombolysis was used in only 1% of patients. Reperfusion therapy was thus used in 87% of all STEMI patients. Discharge medication included aspirin in 95%, a statin in 76%, a beta-blocker in 78%, an ACE inhibitor in 50%, clopidogrel in 60%, and ticlopidine in 4% of patients. Conclusions In-hospital mortality of ACS in the Czech network of PCI and non-PCI hospitals is low. Nationwide application of primary PCI strategy for STEMI is feasible and increases the overall use of reperfusion therapy.</description><identifier>ISSN: 0167-5273</identifier><identifier>EISSN: 1874-1754</identifier><identifier>DOI: 10.1016/j.ijcard.2007.02.036</identifier><identifier>PMID: 17442424</identifier><identifier>CODEN: IJCDD5</identifier><language>eng</language><publisher>Shannon: Elsevier Ireland Ltd</publisher><subject>Acute coronary syndromes ; Acute myocardial infarction ; Adrenergic beta-Antagonists - therapeutic use ; Adult ; Aged ; Aged, 80 and over ; Angina, Unstable - diagnosis ; Angina, Unstable - epidemiology ; Angina, Unstable - therapy ; Angiotensin-Converting Enzyme Inhibitors - therapeutic use ; Biological and medical sciences ; Cardiology. Vascular system ; Cardiovascular ; Coronary Angiography ; Coronary Artery Bypass ; Coronary artery bypass surgery ; Coronary heart disease ; Czech Republic - epidemiology ; Diseases of the cardiovascular system ; Female ; Heart ; Hospital Mortality ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use ; Incidence ; Male ; Medical sciences ; Middle Aged ; Myocardial Infarction - diagnosis ; Myocardial Infarction - epidemiology ; Myocardial Infarction - therapy ; Myocarditis. Cardiomyopathies ; Percutaneous coronary intervention ; Pharmacotheraphy ; Platelet Aggregation Inhibitors - therapeutic use ; Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects) ; Registries ; Registry ; Reperfusion ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Surgery of the heart ; Thrombolytic Therapy - methods ; Treatment Outcome</subject><ispartof>International journal of cardiology, 2007-07, Vol.119 (2), p.212-219</ispartof><rights>Elsevier Ireland Ltd</rights><rights>2007 Elsevier Ireland Ltd</rights><rights>2007 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c511t-1ca40e2fcc44bf738454d55d02c8a875fe76acfd4d9ddc8f39d21c9ee5e13cd3</citedby><cites>FETCH-LOGICAL-c511t-1ca40e2fcc44bf738454d55d02c8a875fe76acfd4d9ddc8f39d21c9ee5e13cd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=18826677$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17442424$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Widimsky, Petr</creatorcontrib><creatorcontrib>Zelizko, Michal</creatorcontrib><creatorcontrib>Jansky, Petr</creatorcontrib><creatorcontrib>Tousek, Frantisek</creatorcontrib><creatorcontrib>Holm, Frantisek</creatorcontrib><creatorcontrib>Aschermann, Michael</creatorcontrib><creatorcontrib>on behalf of the CZECH investigators</creatorcontrib><creatorcontrib>CZECH investigators</creatorcontrib><title>The incidence, treatment strategies and outcomes of acute coronary syndromes in the “reperfusion network” of different hospital types in the Czech Republic: Results of the Czech evaluation of acute coronary syndromes in hospitalized patients (CZECH) registry</title><title>International journal of cardiology</title><addtitle>Int J Cardiol</addtitle><description>Abstract Aims To analyze the incidence, treatment strategies and outcomes of acute coronary syndromes (ACS) in Czech population. Methods and results ACS diagnosis was confirmed in 1345 of 1921 (70%) consecutively admitted patients with suspected ACS. ACS incidence was 3248 cases/million/year and the annual incidence of confirmed myocardial infarction was 1960 per million. In-hospital mortality was 5.1% (10.0% with Q-MI, 4.4% with non-Q-MI, and 0.9% with UAP). Coronary angiography was performed in 92% of STEMI (followed by primary PCI in 83%, by CABG in 3%, by conservative therapy in 6%). Thrombolysis was used in only 1% of patients. Reperfusion therapy was thus used in 87% of all STEMI patients. Discharge medication included aspirin in 95%, a statin in 76%, a beta-blocker in 78%, an ACE inhibitor in 50%, clopidogrel in 60%, and ticlopidine in 4% of patients. Conclusions In-hospital mortality of ACS in the Czech network of PCI and non-PCI hospitals is low. Nationwide application of primary PCI strategy for STEMI is feasible and increases the overall use of reperfusion therapy.</description><subject>Acute coronary syndromes</subject><subject>Acute myocardial infarction</subject><subject>Adrenergic beta-Antagonists - therapeutic use</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Angina, Unstable - diagnosis</subject><subject>Angina, Unstable - epidemiology</subject><subject>Angina, Unstable - therapy</subject><subject>Angiotensin-Converting Enzyme Inhibitors - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Cardiology. Vascular system</subject><subject>Cardiovascular</subject><subject>Coronary Angiography</subject><subject>Coronary Artery Bypass</subject><subject>Coronary artery bypass surgery</subject><subject>Coronary heart disease</subject><subject>Czech Republic - epidemiology</subject><subject>Diseases of the cardiovascular system</subject><subject>Female</subject><subject>Heart</subject><subject>Hospital Mortality</subject><subject>Humans</subject><subject>Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use</subject><subject>Incidence</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Myocardial Infarction - diagnosis</subject><subject>Myocardial Infarction - epidemiology</subject><subject>Myocardial Infarction - therapy</subject><subject>Myocarditis. Cardiomyopathies</subject><subject>Percutaneous coronary intervention</subject><subject>Pharmacotheraphy</subject><subject>Platelet Aggregation Inhibitors - therapeutic use</subject><subject>Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)</subject><subject>Registries</subject><subject>Registry</subject><subject>Reperfusion</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Surgery of the heart</subject><subject>Thrombolytic Therapy - methods</subject><subject>Treatment Outcome</subject><issn>0167-5273</issn><issn>1874-1754</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNqFUs2O0zAQDoifLQtvgJAvIJBosRMnTjggoWphkVZCgh4QF8sdT6i7qR1sZ1H3tA8CL7dPgrMtqsRl5cPY8vfj8TdZ9pTRGaOserOemTUor2c5pWJG8xktqrvZhNWCT5ko-b1skmBiWuaiOMoehbCmlPKmqR9mR0xwnqc1ufNgsUJiLBiNFvA1iR5V3KCNJESvIv4wGIiymrghgtukg2uJgiEiAeedVX5LwtZqf3NnLIlJ7_rqt8cefTsE4yyxGH85f3599Wcka9O26EeHlQu9iaojcdsfyPNLhBX5gv2w7Ay8TbswdPHG93CNF6obVBzVb3nPPxNziZr0iZKcA3k5_34yP31FfGowNbp9nN1vVRfwyb4eZ4sPJ4v56fTs88dP8_dnUygZi1MGilPMWwDOl60oal5yXZaa5lCrWpQtikpBq7lutIa6LRqdM2gQS2QF6OI4e7GT7b37OWCIcmMCYNcpi24IUtBSFBVtEpDvgOBdCB5b2XuzSc1JRuUYv1zLXfxyjF_SXKb4E-3ZXn9YblAfSPu8E-D5HqACqK71KkUfDri6zqtKiIR7t8Nh-owLg14GMOOEaOMRotTO3PaS_wWgM9Ykz3PcYli7wdv00ZLJkAjy6ziq46RSQWmq34q_3VXuaw</recordid><startdate>20070710</startdate><enddate>20070710</enddate><creator>Widimsky, Petr</creator><creator>Zelizko, Michal</creator><creator>Jansky, Petr</creator><creator>Tousek, Frantisek</creator><creator>Holm, Frantisek</creator><creator>Aschermann, Michael</creator><general>Elsevier Ireland Ltd</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20070710</creationdate><title>The incidence, treatment strategies and outcomes of acute coronary syndromes in the “reperfusion network” of different hospital types in the Czech Republic: Results of the Czech evaluation of acute coronary syndromes in hospitalized patients (CZECH) registry</title><author>Widimsky, Petr ; Zelizko, Michal ; Jansky, Petr ; Tousek, Frantisek ; Holm, Frantisek ; Aschermann, Michael</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c511t-1ca40e2fcc44bf738454d55d02c8a875fe76acfd4d9ddc8f39d21c9ee5e13cd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Acute coronary syndromes</topic><topic>Acute myocardial infarction</topic><topic>Adrenergic beta-Antagonists - therapeutic use</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Angina, Unstable - diagnosis</topic><topic>Angina, Unstable - epidemiology</topic><topic>Angina, Unstable - therapy</topic><topic>Angiotensin-Converting Enzyme Inhibitors - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Cardiology. Vascular system</topic><topic>Cardiovascular</topic><topic>Coronary Angiography</topic><topic>Coronary Artery Bypass</topic><topic>Coronary artery bypass surgery</topic><topic>Coronary heart disease</topic><topic>Czech Republic - epidemiology</topic><topic>Diseases of the cardiovascular system</topic><topic>Female</topic><topic>Heart</topic><topic>Hospital Mortality</topic><topic>Humans</topic><topic>Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use</topic><topic>Incidence</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Myocardial Infarction - diagnosis</topic><topic>Myocardial Infarction - epidemiology</topic><topic>Myocardial Infarction - therapy</topic><topic>Myocarditis. Cardiomyopathies</topic><topic>Percutaneous coronary intervention</topic><topic>Pharmacotheraphy</topic><topic>Platelet Aggregation Inhibitors - therapeutic use</topic><topic>Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)</topic><topic>Registries</topic><topic>Registry</topic><topic>Reperfusion</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Surgery of the heart</topic><topic>Thrombolytic Therapy - methods</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Widimsky, Petr</creatorcontrib><creatorcontrib>Zelizko, Michal</creatorcontrib><creatorcontrib>Jansky, Petr</creatorcontrib><creatorcontrib>Tousek, Frantisek</creatorcontrib><creatorcontrib>Holm, Frantisek</creatorcontrib><creatorcontrib>Aschermann, Michael</creatorcontrib><creatorcontrib>on behalf of the CZECH investigators</creatorcontrib><creatorcontrib>CZECH investigators</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Widimsky, Petr</au><au>Zelizko, Michal</au><au>Jansky, Petr</au><au>Tousek, Frantisek</au><au>Holm, Frantisek</au><au>Aschermann, Michael</au><aucorp>on behalf of the CZECH investigators</aucorp><aucorp>CZECH investigators</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The incidence, treatment strategies and outcomes of acute coronary syndromes in the “reperfusion network” of different hospital types in the Czech Republic: Results of the Czech evaluation of acute coronary syndromes in hospitalized patients (CZECH) registry</atitle><jtitle>International journal of cardiology</jtitle><addtitle>Int J Cardiol</addtitle><date>2007-07-10</date><risdate>2007</risdate><volume>119</volume><issue>2</issue><spage>212</spage><epage>219</epage><pages>212-219</pages><issn>0167-5273</issn><eissn>1874-1754</eissn><coden>IJCDD5</coden><abstract>Abstract Aims To analyze the incidence, treatment strategies and outcomes of acute coronary syndromes (ACS) in Czech population. Methods and results ACS diagnosis was confirmed in 1345 of 1921 (70%) consecutively admitted patients with suspected ACS. ACS incidence was 3248 cases/million/year and the annual incidence of confirmed myocardial infarction was 1960 per million. In-hospital mortality was 5.1% (10.0% with Q-MI, 4.4% with non-Q-MI, and 0.9% with UAP). Coronary angiography was performed in 92% of STEMI (followed by primary PCI in 83%, by CABG in 3%, by conservative therapy in 6%). Thrombolysis was used in only 1% of patients. Reperfusion therapy was thus used in 87% of all STEMI patients. Discharge medication included aspirin in 95%, a statin in 76%, a beta-blocker in 78%, an ACE inhibitor in 50%, clopidogrel in 60%, and ticlopidine in 4% of patients. Conclusions In-hospital mortality of ACS in the Czech network of PCI and non-PCI hospitals is low. Nationwide application of primary PCI strategy for STEMI is feasible and increases the overall use of reperfusion therapy.</abstract><cop>Shannon</cop><pub>Elsevier Ireland Ltd</pub><pmid>17442424</pmid><doi>10.1016/j.ijcard.2007.02.036</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0167-5273
ispartof International journal of cardiology, 2007-07, Vol.119 (2), p.212-219
issn 0167-5273
1874-1754
language eng
recordid cdi_proquest_miscellaneous_70573609
source Elsevier
subjects Acute coronary syndromes
Acute myocardial infarction
Adrenergic beta-Antagonists - therapeutic use
Adult
Aged
Aged, 80 and over
Angina, Unstable - diagnosis
Angina, Unstable - epidemiology
Angina, Unstable - therapy
Angiotensin-Converting Enzyme Inhibitors - therapeutic use
Biological and medical sciences
Cardiology. Vascular system
Cardiovascular
Coronary Angiography
Coronary Artery Bypass
Coronary artery bypass surgery
Coronary heart disease
Czech Republic - epidemiology
Diseases of the cardiovascular system
Female
Heart
Hospital Mortality
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use
Incidence
Male
Medical sciences
Middle Aged
Myocardial Infarction - diagnosis
Myocardial Infarction - epidemiology
Myocardial Infarction - therapy
Myocarditis. Cardiomyopathies
Percutaneous coronary intervention
Pharmacotheraphy
Platelet Aggregation Inhibitors - therapeutic use
Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)
Registries
Registry
Reperfusion
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Surgery of the heart
Thrombolytic Therapy - methods
Treatment Outcome
title The incidence, treatment strategies and outcomes of acute coronary syndromes in the “reperfusion network” of different hospital types in the Czech Republic: Results of the Czech evaluation of acute coronary syndromes in hospitalized patients (CZECH) registry
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T21%3A26%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20incidence,%20treatment%20strategies%20and%20outcomes%20of%20acute%20coronary%20syndromes%20in%20the%20%E2%80%9Creperfusion%20network%E2%80%9D%20of%20different%20hospital%20types%20in%20the%20Czech%20Republic:%20Results%20of%20the%20Czech%20evaluation%20of%20acute%20coronary%20syndromes%20in%20hospitalized%20patients%20(CZECH)%20registry&rft.jtitle=International%20journal%20of%20cardiology&rft.au=Widimsky,%20Petr&rft.aucorp=on%20behalf%20of%20the%20CZECH%20investigators&rft.date=2007-07-10&rft.volume=119&rft.issue=2&rft.spage=212&rft.epage=219&rft.pages=212-219&rft.issn=0167-5273&rft.eissn=1874-1754&rft.coden=IJCDD5&rft_id=info:doi/10.1016/j.ijcard.2007.02.036&rft_dat=%3Cproquest_cross%3E70573609%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c511t-1ca40e2fcc44bf738454d55d02c8a875fe76acfd4d9ddc8f39d21c9ee5e13cd3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=70573609&rft_id=info:pmid/17442424&rfr_iscdi=true